ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Immunologists Boycott USSR Trip; Centers Program Staff Reorganized, Trimmed Down

June 2, 1978

Opioid Pain Reliever Approved With Risk Reduction Plan

July 31, 2009

New Grant Program in Physical Activity

March 28, 2003

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005

Norris Cotton Cancer Center wins core grant renewal.

October 10, 2003